Dr Ezra Cohen | Associate Director of Moores Cancer Center
U.C. San Diego Moores Cancer Center

Dr Ezra Cohen, Associate Director of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Ezra Cohen, MD, is co-Director of the San Diego Center for Precision Immunotherapy and an internationally renowned translational researcher. A physician-scientist, Dr.Cohen led an independently funded laboratory interested in mechanisms of action of novel therapeutics. He has made major contributions to targeted therapy. His recent National Institutes of Health-funded work in the study of epidermal growth factor receptor inhibitors in head and neck cancer has contributed to the understanding of the biology of this critical signaling network, integration of these agents into standard of care, and definition of mechanisms to overcome resistance. He recently served as chair of the NCI Head and Neck Cancer Steering Committee that oversees NCI-funded clinical research (including all NCI Cooperative Group trials) in this disease.
Dr. Cohen is Associate Director for Translational Science and leader of the Solid Tumor Therapeutics researchprogram at Moores Cancer Center. He brings his expertise and preeminent reputation in head and neck cancerresearch and patient care to solid tumor therapeutics. Among other roles, he is chair of the Protocol Reviewand Monitoring Committee (PRMC) and serves as a member of the Cancer Council, and the Cancer Center’s Executive Committee. Dr. Cohen recently served as editor-in-chief of Oral Oncology, the highest impact specialty journal in head andneck cancer, and has recently chaired two Multidisciplinary Head and Neck Cancer Symposia—the largestinternational meeting of its kind—sponsored by the American Society for Radiation Oncology, the American Society of Clinical Oncology and the American Head and Neck Society. He has been the principal investigator on multiple studies of novel agents in head and neck cancer and other solid tumors in all phases of development including chemoprevention, phase I, II, and III trials. Dr. Cohen has authored more than 170 papers and has presented his research at national and international meetings. In addition, he has served as a grant reviewer for the NIH, American Association for Cancer Research, American Society of Clinical Oncology, and the Ontario Institute for Cancer Research. Dr. Cohen completed residencies in Family Medicine at the University of Toronto and in Internal Medicine at Albert Einstein College of Medicine. He completed a Hematology/Oncology fellowship at the University of Chicago where he was named chief fellow. Prior to his arrival in San Diego, Dr. Cohen was Co-Director of the Head and Neck Cancer Program, Associate Director for Education and Program Director for the Hematology/Oncology Fellowship at the University of Chicago Comprehensive Cancer Center. A dedicated educator, Dr. Cohen also mentored and developed young faculty in his program.


Agenda Day 1 @ 08:40

Status of US vaccine and immunotherapy research in 2017 and beyond

  • Drivers moving the immunotherapy sector forward and its potential
  • Hurdles in vaccines research and the consequence of antivaxxers in national immunity
  • What regulatory or policy changes could affect the science, technology and funding to this sector?

back to speakers